Osteoporosis Flashcards

1
Q

How is osteoporosis defined clinically?

A

Low bone mass defined by distance from standard deviation on DEXA score

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Differentiate osteoblasts from osteoclasts.

A

Osteoblasts: build bone
Osteoclasts: break down bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the biggest risk factor for osteoporosis?

A

Estrogen deficiency, particularly after menopause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

T/F: Women over the age of 65 lose bone mass at a faster rate than males of the same age.

A

False: but women have lower bone mass to start with, so they are at greater risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List 8 risk factors for developing osteoporosis.

A

Advancing age, poor calcium and vitamin D intake, glucocorticoid therapy, low body weight, smoking, excessive alcohol, sedentary lifestyle, overuse of aluminum containing antacids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How much of a steroid dose is needed to decrease bone mass?

A

Daily dose of 5mg of prednisone (or equivalent) for 3 or more months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List some non-pharmacologic interventions indicated for osteoporosis patients.

A

Smoke and alcohol cessation, fall prevention, regular weight bearing exercise, adequate intake of calcium and vitamin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the three salt forms of calcium in terms of the elemental calcium each form delivers.

A

Ca carbonate: delivers 40% elemental calcium
Ca citrate: delivers 24% elemental calcium
Ca gluconate: minimal elemental calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What patients should avoid taking calcium carbonate and why?

A

Patients taking PPIs or H2RAs –> calcium carbonate requires acid to be absorbed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the AEs of calcium supplementation?

A

GI effects - constipation, nausea, gas, etc.
Hypercalcemia - especially when combined with a thiazide
Hypophosphatemia - calcium binds phosphate
Kidney stones (hypercalciuria)
Chelator (Ca carbonate) - binds quinolones, tetracyclines, bisphosphonates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the mechanism of action of vitamin D supplementation as it relates to osteoporosis.

A

Vitamin D is required for the intestinal absorption of calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List and describe the three forms by which vitamin D is available.

A

Ergocalciferol (D2): requires 1-alpha-hydroxylation in kidneys to convert to active form
Cholecalciferol (D3): also requires 1-alpha-hydroxylation and is naturally formed in the skin via sunlight
Calcitriol (1,25(OH)D3): does not require 1-alpha-hydroxylation –> best for CKD patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T/F: Vitamin D is a fat soluble vitamin that is absorbed in the stomach.

A

False: Fat soluble but it is absorbed in the intestines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

T/F: All vitamin D supplement forms are available OTC.

A

False: higher strength vitamin D is available by prescription only and may be available by injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the mainstay of osteoporosis therapy?

A

Bisphosphonates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the indications (including off-label uses) for bisphosphonate use?

A

Osteoporosis, Paget’s Disease, bone metastases

Off-label: decreased bone mineral density from IBD, hypercalcemia of malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the mechanism of action of bisphosphonates.

A

Incorporated into bone in areas of active bone remodeling. There they decrease activity of osteoclasts allowing osteoblast activity to prevail

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe the duration of activity of bisphosphonates.

A

Long duration because they are incorporated in the bone matrix.

19
Q

Name and describe the first bisphosphonate.

A

Alendronate: first and least expensive, many dosing options (qd tablet, qw tablet, liquid)

20
Q

Describe the 30 minute rule of bisphosphonates and describe how Ibandronate is different.

A

Patients must take most bisphosphonates 30 minutes before eating and remain standing for 30 minutes after to allow the drug to travel easily down the esophagus and into the stomach –> risk for esophageal ulcers. Ibandronate requires 60 minutes standing.

21
Q

T/F: Ibandronate is only available as a PO tablet.

A

False: It is also available IV

22
Q

What is unique about the administration of Risedronate?

A

Must be taken with water immediately AFTER breakfast

23
Q

Describe the administration of Zoledronic Acid.

A

It is administered IV once per year.

24
Q

List the disadvantages of Zoledronic Acid.

A

Expensive, may cause nephrotoxicity and infusion reactions.

25
What are 5 precautions associated with all bisphosphonates?
GI issues - N/V/D, constipation, abdominal pain Flu-like symptoms - HA, fever Arthralgia, myalgia, bone pain Hypocalcemia Osteonecrosis of jaw - caution in patients with poor oral hygiene
26
What are the contraindications of bisphosphonate use?
GI ulcers and erosions, esophagitis, pharyngitis, esophageal cancer, delayed gastric emptying
27
What is the primary reason people are unable to tolerate bisphosphonates?
GI upset
28
Describe the mechanism of action of selective estrogen receptor modulators (SERM).
Agonize estrogen receptors on bone but antagonize estrogen receptors on uterine and breast tissue
29
What is the broad-view explanation as to why agonizing estrogen in bone helps osteoporosis?
Estrogen decreases osteoclast activity
30
Name and give the indications for the one SERM discussed in class.
Raloxifene - postmenopausal osteoporosis, prevention of estrogen receptor positive breast cancer in post menopausal women.
31
What affect do SERM medications have on lipids?
Decrease LDL, but no effect on HDL or triglycerides
32
What are the AEs of SERMs?
Decrease bone density in premenopausal women Vasomotor symptoms --> hot flashes Leg cramping Use caution in patients with impending prolonged immobilization Contraindicated in pregnancy May decrease INR (blood clots faster) in patients taking warfarin
33
What is the black box warning for SERMs?
Increased risk of venous thromboembolism
34
What are the two ways by which calcitonin may be administered?
Intranasal or injection --> calcitonin is not hot
35
When is estrogen replacement therapy indicated for postmenopausal women and why?
Only when they have severe vasomotor symptoms --> not used as much anymore s/p increased risk of clots
36
What are the three black box warnings for estrogen replacement therapy?
Increased risk of endometrial and other uterine/ovarian cancers Increased risk of breast cancer Increased risk of venous thromboembolism
37
Describe the use of parathyroid hormone (PTH) for osteoporosis.
Not hot --> patients on PTH have issues
38
How is PTH administered?
Subcutaneous injection
39
Describe the mechanism of action of RANK-L inhibitors.
RANK binding to RANK-L receptors activates osteoclasts. Blocking RANK-L decreases bone breakdown.
40
Name the one RANK-L medication and state what kind of drug it is.
Denosumab - monoclonal antibody
41
How is denosumab administered?
Subcutaneous injection every 6 months.
42
What are the common AEs of denosumab?
GI effects, limb/back pain, fatigue, osteonecrosis of the jaw, increased risk of infections in certain cancers
43
What blood lab must be obtained before administering denosumab?
Serum calcium - calcium must be normal before administering denosumab
44
Summarize the second-line options to consider in patients unable to tolerate a bisphosphonate?
IV zoledronic acid is first line in patients unable to take bisphosphonates SERMs in postmenopausal women Denosumab subcutaneous injection